StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
SCHOTT Pharma AG & Co. KGaA
Frankfurt Stock Exchange:1SXP.F
Sector
Location
Market Cap
USD 4.66 B
Share Price
USD 29.88
Avg Daily Volume
165
Change (1 day)
0.15%
Change (1 year)
-11.65%
Change (YTD)
14.14%
SCHOTT Pharma AG & Co. KGaA Operating Cash Flow for the year ending September 30, 2024: USD 250.89 M
SCHOTT Pharma AG & Co. KGaA Operating Cash Flow is USD 250.89 M for the year ending September 30, 2024, a 30.62% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
SCHOTT Pharma AG & Co. KGaA Operating Cash Flow for the year ending September 30, 2023 was USD 192.08 M, a 7.61% change year over year.
-
SCHOTT Pharma AG & Co. KGaA Operating Cash Flow for the year ending September 30, 2022 was USD 178.49 M, a 16.63% change year over year.
-
SCHOTT Pharma AG & Co. KGaA Operating Cash Flow for the year ending September 30, 2021 was USD 153.04 M, a 25.09% change year over year.
-
SCHOTT Pharma AG & Co. KGaA Operating Cash Flow for the year ending September 30, 2020 was USD 122.34 M.
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 46.51
4519.T
-0.57
-1.20%
West Pharmaceutical Services, Inc.
USD 226.18
WST
+5.70
2.58%
Yuhan Corporation
USD 79.06
000100.KS
+1.92
2.49%
Gan & Lee Pharmaceuticals.
USD 7.66
603087.SS
+0.05
0.65%
Cohance Lifesciences Limited
USD 11.57
COHANCE.NS
-0.07
-0.64%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 2.94
600521.SS
-0.15
-4.81%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.10
600867.SS
+0.00
0.17%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.22
300009.SZ
-0.00
-0.20%
Anbio Biotechnology Class A Ordinary Shares
USD 51.81
NNNN
+6.56
14.50%
Neuland Laboratories Limited
USD 139.77
NEULANDLAB.NS
+3.24
2.37%
Qingdao Baheal Medical Inc.
USD 2.89
301015.SZ
-0.07
-2.35%
Eli Lilly and Company
USD 786.92
LLY
+9.26
1.19%
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 46.51
4519.T
-0.57
-1.20%
West Pharmaceutical Services, Inc.
USD 226.18
WST
+5.70
2.58%
Yuhan Corporation
USD 79.06
000100.KS
+1.92
2.49%
Gan & Lee Pharmaceuticals.
USD 7.66
603087.SS
+0.05
0.65%
Cohance Lifesciences Limited
USD 11.57
COHANCE.NS
-0.07
-0.64%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 2.94
600521.SS
-0.15
-4.81%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.10
600867.SS
+0.00
0.17%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.22
300009.SZ
-0.00
-0.20%
Anbio Biotechnology Class A Ordinary Shares
USD 51.81
NNNN
+6.56
14.50%
Neuland Laboratories Limited
USD 139.77
NEULANDLAB.NS
+3.24
2.37%
Qingdao Baheal Medical Inc.
USD 2.89
301015.SZ
-0.07
-2.35%
Eli Lilly and Company
USD 786.92
LLY
+9.26
1.19%
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%